|1.||Epstein, Jonathan I: 3 articles (03/2015 - 09/2007)|
|2.||Perner, Sven: 2 articles (01/2015 - 02/2013)|
|3.||Braun, Martin: 2 articles (01/2015 - 02/2013)|
|4.||Parwani, Anil V: 2 articles (01/2011 - 01/2007)|
|5.||Wirth, Manfred P: 2 articles (10/2006 - 06/2006)|
|6.||Meye, Axel: 2 articles (10/2006 - 06/2006)|
|7.||Fuessel, Susanne: 2 articles (10/2006 - 06/2006)|
|8.||Kalos, Michael: 2 articles (08/2004 - 04/2004)|
|9.||Scoggin, Tatiana: 1 article (06/2015)|
|10.||Tacha, David: 1 article (06/2015)|
|1.||Prostatic Neoplasms (Prostate Cancer)
02/15/2013 - "Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical course."
03/01/2008 - "Transfection of synthetic miR-126* into prostate cancer LNCaP cells strongly reduced the translation of prostein. "
09/01/2007 - "Owing to its apparent specificity, prostein may be a good marker to demonstrate prostatic origin in metastatic prostate cancer. "
08/01/2004 - "Prostein is exquisitely specific for prostate tissues, indicating a potential clinical utility of 10E3-G4-D3 as a diagnostic biomarker, and support the use of prostein as a novel target for development of prostein-specific antibody and T-cell based therapeutic strategies for prostate cancer."
04/01/2004 - "The identification of a prostein-specific CD8 T cell repertoire supports the development of prostein in vaccination strategies against prostate cancer. "
06/15/2015 - "Cells captured on the membrane were assayed for PSA and Prostein expression to identify prostate epithelial cells, and for ERG and AMACR to identify prostate tumor cells. "
01/01/2011 - "We evaluated the diagnostic utility of a dual immunohistochemical stain comprising p63 and P501S (prostein), applied sequentially on a single slide and visualized by double chromogen reaction, in differentiating these two cancers. "
10/01/2006 - "A multivariate logit model for the predictability of the tumor was developed, which employed the relative expression levels of EZH2, PCA3, prostein, and TRPM8 and yielded an AUC of 0.90. "
08/01/2004 - "A murine monoclonal antibody was developed, characterized, and used to evaluate the expression of prostein protein in prostatic, other normal tissue and tumor samples. "
09/11/2008 - "Evaluation of the transcriptome and specific gene promoters in ERG siRNA-treated cells and investigation of gene expression signatures of human prostate tumors revealed ERG-mediated activation of C-MYC oncogene and the repression of prostate epithelial differentiation genes (PSA and SLC45A3/Prostein). "
06/01/2012 - "The results revealed the panels of immunohistochemical markers for the differential diagnosis of rectal adenocarcinoma, in which [+] designates positivity in rectal adenocarcinoma and [-] designates negativity in rectal adenocarcinoma: from bladder adenocarcinoma, CDX2[+], VIL1[+], KRT7[-], THBD[-] and UPK3A[-]; from prostate adenocarcinoma, CDX2[+], VIL1[+], CEACAM5[+], KLK3(PSA)[-], ACPP(PAP)[-] and SLC45A3(prostein)[-]; and from ovarian mucinous adenocarcinoma, CEACAM5[+], VIL1[+], CDX2[+], KRT7[-] and MUC5AC[-]. "
01/01/2007 - "Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma."
|4.||Small Cell Carcinoma
|5.||Neoplasm Metastasis (Metastasis)
01/01/2015 - "Expression of prostate-specific antigen, prostate-specific acid phosphatase, androgen receptor, prostate-specific membrane antigen, prostein, and ETS-related gene was determined on archived tissue specimens consisting of benign prostatic tissue (n=9), primary prostate cancer (n=79), lymph node metastases (n=58), and distant metastases (n=39) using immunohistochemistry. "
01/01/2015 - "The widely used prostate cancer markers such as prostate-specific antigen, prostate-specific acid phosphatase, androgen receptor, prostate-specific membrane antigen, prostein, and ETS-related gene were investigated for their sensitivity to detect prostatic origin of metastases. "
|1.||Prostate-Specific Antigen (Semenogelase)
|2.||human glutamate carboxypeptidase II
|3.||Messenger RNA (mRNA)
|4.||Androgen Receptors (Androgen Receptor)
|6.||Small Interfering RNA (siRNA)
|7.||T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)
|8.||Proteins (Proteins, Gene)
|1.||Prostatectomy (Retropubic Prostatectomy)